Effect of stereochemistry on the anti-HIV activity of chiral thiourea compounds

Chiral derivatives of several substituted halopyridyl and thiazolyl PETT compounds were synthesized as non-nucleoside inhibitors of the reverse transcriptase (RT) enzyme (NNRTI) of the human immunodeficiency virus (HIV-1). Molecular modeling studies indicated that because of the asymmetric geometry...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry 2004-08, Vol.12 (15), p.4275-4284
Hauptverfasser: Venkatachalam, T.K, Mao, C, Uckun, Fatih.M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4284
container_issue 15
container_start_page 4275
container_title Bioorganic & medicinal chemistry
container_volume 12
creator Venkatachalam, T.K
Mao, C
Uckun, Fatih.M
description Chiral derivatives of several substituted halopyridyl and thiazolyl PETT compounds were synthesized as non-nucleoside inhibitors of the reverse transcriptase (RT) enzyme (NNRTI) of the human immunodeficiency virus (HIV-1). Molecular modeling studies indicated that because of the asymmetric geometry of the NNRTI binding pocket, the R stereoisomers would fit the NNRTI binding pocket of the HIV-1 RT much better than the corresponding S stereoisomers, as reflected by their 10 4-fold lower K i values. Chiral derivatives of several substituted halopyridyl and thiazolyl PETT compounds were synthesized as non-nucleoside inhibitors of the reverse transcriptase (RT) enzyme (NNRTI) of the human immunodeficiency virus (HIV-1). Molecular modeling studies indicated that because of the asymmetric geometry of the NNRTI binding pocket, the R stereoisomers would fit the NNRTI binding pocket of the HIV-1 RT much better than the corresponding S stereoisomers, as reflected by their 10 4-fold lower K i values. The R stereoisomers of several PETT derivatives inhibited recombinant RT in vitro with lower IC 50 values than their enantiomers. The active compounds were further evaluated for their ability to inhibit HIV-1 replication in human peripheral blood mononuclear cells (PBMC). All the R isomers once again showed potent anti-HIV activity and inhibited the replication of the HIV-1 strain HTLVIIIB in peripheral blood mononuclear cells (PBMC) at nanomolar concentrations whereas their enantiomers were substantially less potent. The lead compounds in the respective groups were further tested against the NNRTI-resistant HIV strains, A17 (Y181C mutant), and A17Var (Y181C+K103N mutant) and RT MDR (V106N). The results showed that the lead compounds were several logs more potent than the standard NNRTI nevirapine. Structure–activity relationship studies also revealed a preference for the pyridyl unit with halo substitutions primarily at 5-position demonstrating the importance of regiochemistry. Our data provides experimental evidence that the stereochemistry as well as regiochemistry of NNRTI can profoundly affect their anti-HIV activity.
doi_str_mv 10.1016/j.bmc.2004.04.050
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66695811</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S096808960400389X</els_id><sourcerecordid>66695811</sourcerecordid><originalsourceid>FETCH-LOGICAL-c445t-f07019211eb146d7f7c35c131afbc835e8e8b2cf6d7c07c0638c65701b40a3e73</originalsourceid><addsrcrecordid>eNp9kMFq3DAQhkVpaDZpHyCX4Et782ZkS1qbnEJIk0Agl7RXIY9HrBbb2kpyYN--MrvQngI_zGG-fxg-xq44rDlwdbNbdyOuKwCxXiLhE1txoURZ1y3_zFbQqqaEplXn7CLGHQBUouVf2DmXlVAcxIq9PlhLmApvi5gokMctjS6mcCj8VKQtFWZKrnx6_l0YTO7dpcPC4tYFM-S983MgU6Af936e-viVnVkzRPp2mpfs18-Ht_un8uX18fn-7qVEIWQqLWyAtxXn1OWH-43dYC2R19zYDptaUkNNV6HNK4QcVTeoZO50AkxNm_qS_Tje3Qf_Z6aYdP4aaRjMRH6OWinVyobzDPIjiMHHGMjqfXCjCQfNQS8W9U5ni3qxqJdIyJ3r0_G5G6n_1zhpy8D3E2AimsEGM6GL_3GthEZWmbs9cpRVvDsKOqKjCal3IVvXvXcfvPEXGKmO4A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66695811</pqid></control><display><type>article</type><title>Effect of stereochemistry on the anti-HIV activity of chiral thiourea compounds</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Venkatachalam, T.K ; Mao, C ; Uckun, Fatih.M</creator><creatorcontrib>Venkatachalam, T.K ; Mao, C ; Uckun, Fatih.M</creatorcontrib><description>Chiral derivatives of several substituted halopyridyl and thiazolyl PETT compounds were synthesized as non-nucleoside inhibitors of the reverse transcriptase (RT) enzyme (NNRTI) of the human immunodeficiency virus (HIV-1). Molecular modeling studies indicated that because of the asymmetric geometry of the NNRTI binding pocket, the R stereoisomers would fit the NNRTI binding pocket of the HIV-1 RT much better than the corresponding S stereoisomers, as reflected by their 10 4-fold lower K i values. Chiral derivatives of several substituted halopyridyl and thiazolyl PETT compounds were synthesized as non-nucleoside inhibitors of the reverse transcriptase (RT) enzyme (NNRTI) of the human immunodeficiency virus (HIV-1). Molecular modeling studies indicated that because of the asymmetric geometry of the NNRTI binding pocket, the R stereoisomers would fit the NNRTI binding pocket of the HIV-1 RT much better than the corresponding S stereoisomers, as reflected by their 10 4-fold lower K i values. The R stereoisomers of several PETT derivatives inhibited recombinant RT in vitro with lower IC 50 values than their enantiomers. The active compounds were further evaluated for their ability to inhibit HIV-1 replication in human peripheral blood mononuclear cells (PBMC). All the R isomers once again showed potent anti-HIV activity and inhibited the replication of the HIV-1 strain HTLVIIIB in peripheral blood mononuclear cells (PBMC) at nanomolar concentrations whereas their enantiomers were substantially less potent. The lead compounds in the respective groups were further tested against the NNRTI-resistant HIV strains, A17 (Y181C mutant), and A17Var (Y181C+K103N mutant) and RT MDR (V106N). The results showed that the lead compounds were several logs more potent than the standard NNRTI nevirapine. Structure–activity relationship studies also revealed a preference for the pyridyl unit with halo substitutions primarily at 5-position demonstrating the importance of regiochemistry. Our data provides experimental evidence that the stereochemistry as well as regiochemistry of NNRTI can profoundly affect their anti-HIV activity.</description><identifier>ISSN: 0968-0896</identifier><identifier>EISSN: 1464-3391</identifier><identifier>DOI: 10.1016/j.bmc.2004.04.050</identifier><identifier>PMID: 15246104</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Anti-HIV Agents - chemical synthesis ; Anti-HIV Agents - chemistry ; Anti-HIV Agents - pharmacology ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiviral agents ; Biological and medical sciences ; Drug Evaluation, Preclinical ; HIV-1 - drug effects ; Humans ; Medical sciences ; Models, Molecular ; Molecular Conformation ; Pharmacology. Drug treatments ; Reverse Transcriptase Inhibitors - chemical synthesis ; Reverse Transcriptase Inhibitors - chemistry ; Reverse Transcriptase Inhibitors - pharmacology ; Stereoisomerism ; Structure-Activity Relationship ; Thiourea - chemical synthesis ; Thiourea - chemistry ; Thiourea - pharmacology ; Virus Replication - drug effects</subject><ispartof>Bioorganic &amp; medicinal chemistry, 2004-08, Vol.12 (15), p.4275-4284</ispartof><rights>2004 Elsevier Ltd</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c445t-f07019211eb146d7f7c35c131afbc835e8e8b2cf6d7c07c0638c65701b40a3e73</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S096808960400389X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15950852$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15246104$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Venkatachalam, T.K</creatorcontrib><creatorcontrib>Mao, C</creatorcontrib><creatorcontrib>Uckun, Fatih.M</creatorcontrib><title>Effect of stereochemistry on the anti-HIV activity of chiral thiourea compounds</title><title>Bioorganic &amp; medicinal chemistry</title><addtitle>Bioorg Med Chem</addtitle><description>Chiral derivatives of several substituted halopyridyl and thiazolyl PETT compounds were synthesized as non-nucleoside inhibitors of the reverse transcriptase (RT) enzyme (NNRTI) of the human immunodeficiency virus (HIV-1). Molecular modeling studies indicated that because of the asymmetric geometry of the NNRTI binding pocket, the R stereoisomers would fit the NNRTI binding pocket of the HIV-1 RT much better than the corresponding S stereoisomers, as reflected by their 10 4-fold lower K i values. Chiral derivatives of several substituted halopyridyl and thiazolyl PETT compounds were synthesized as non-nucleoside inhibitors of the reverse transcriptase (RT) enzyme (NNRTI) of the human immunodeficiency virus (HIV-1). Molecular modeling studies indicated that because of the asymmetric geometry of the NNRTI binding pocket, the R stereoisomers would fit the NNRTI binding pocket of the HIV-1 RT much better than the corresponding S stereoisomers, as reflected by their 10 4-fold lower K i values. The R stereoisomers of several PETT derivatives inhibited recombinant RT in vitro with lower IC 50 values than their enantiomers. The active compounds were further evaluated for their ability to inhibit HIV-1 replication in human peripheral blood mononuclear cells (PBMC). All the R isomers once again showed potent anti-HIV activity and inhibited the replication of the HIV-1 strain HTLVIIIB in peripheral blood mononuclear cells (PBMC) at nanomolar concentrations whereas their enantiomers were substantially less potent. The lead compounds in the respective groups were further tested against the NNRTI-resistant HIV strains, A17 (Y181C mutant), and A17Var (Y181C+K103N mutant) and RT MDR (V106N). The results showed that the lead compounds were several logs more potent than the standard NNRTI nevirapine. Structure–activity relationship studies also revealed a preference for the pyridyl unit with halo substitutions primarily at 5-position demonstrating the importance of regiochemistry. Our data provides experimental evidence that the stereochemistry as well as regiochemistry of NNRTI can profoundly affect their anti-HIV activity.</description><subject>Anti-HIV Agents - chemical synthesis</subject><subject>Anti-HIV Agents - chemistry</subject><subject>Anti-HIV Agents - pharmacology</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiviral agents</subject><subject>Biological and medical sciences</subject><subject>Drug Evaluation, Preclinical</subject><subject>HIV-1 - drug effects</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Models, Molecular</subject><subject>Molecular Conformation</subject><subject>Pharmacology. Drug treatments</subject><subject>Reverse Transcriptase Inhibitors - chemical synthesis</subject><subject>Reverse Transcriptase Inhibitors - chemistry</subject><subject>Reverse Transcriptase Inhibitors - pharmacology</subject><subject>Stereoisomerism</subject><subject>Structure-Activity Relationship</subject><subject>Thiourea - chemical synthesis</subject><subject>Thiourea - chemistry</subject><subject>Thiourea - pharmacology</subject><subject>Virus Replication - drug effects</subject><issn>0968-0896</issn><issn>1464-3391</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMFq3DAQhkVpaDZpHyCX4Et782ZkS1qbnEJIk0Agl7RXIY9HrBbb2kpyYN--MrvQngI_zGG-fxg-xq44rDlwdbNbdyOuKwCxXiLhE1txoURZ1y3_zFbQqqaEplXn7CLGHQBUouVf2DmXlVAcxIq9PlhLmApvi5gokMctjS6mcCj8VKQtFWZKrnx6_l0YTO7dpcPC4tYFM-S983MgU6Af936e-viVnVkzRPp2mpfs18-Ht_un8uX18fn-7qVEIWQqLWyAtxXn1OWH-43dYC2R19zYDptaUkNNV6HNK4QcVTeoZO50AkxNm_qS_Tje3Qf_Z6aYdP4aaRjMRH6OWinVyobzDPIjiMHHGMjqfXCjCQfNQS8W9U5ni3qxqJdIyJ3r0_G5G6n_1zhpy8D3E2AimsEGM6GL_3GthEZWmbs9cpRVvDsKOqKjCal3IVvXvXcfvPEXGKmO4A</recordid><startdate>20040801</startdate><enddate>20040801</enddate><creator>Venkatachalam, T.K</creator><creator>Mao, C</creator><creator>Uckun, Fatih.M</creator><general>Elsevier Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20040801</creationdate><title>Effect of stereochemistry on the anti-HIV activity of chiral thiourea compounds</title><author>Venkatachalam, T.K ; Mao, C ; Uckun, Fatih.M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c445t-f07019211eb146d7f7c35c131afbc835e8e8b2cf6d7c07c0638c65701b40a3e73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Anti-HIV Agents - chemical synthesis</topic><topic>Anti-HIV Agents - chemistry</topic><topic>Anti-HIV Agents - pharmacology</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiviral agents</topic><topic>Biological and medical sciences</topic><topic>Drug Evaluation, Preclinical</topic><topic>HIV-1 - drug effects</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Models, Molecular</topic><topic>Molecular Conformation</topic><topic>Pharmacology. Drug treatments</topic><topic>Reverse Transcriptase Inhibitors - chemical synthesis</topic><topic>Reverse Transcriptase Inhibitors - chemistry</topic><topic>Reverse Transcriptase Inhibitors - pharmacology</topic><topic>Stereoisomerism</topic><topic>Structure-Activity Relationship</topic><topic>Thiourea - chemical synthesis</topic><topic>Thiourea - chemistry</topic><topic>Thiourea - pharmacology</topic><topic>Virus Replication - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Venkatachalam, T.K</creatorcontrib><creatorcontrib>Mao, C</creatorcontrib><creatorcontrib>Uckun, Fatih.M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic &amp; medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Venkatachalam, T.K</au><au>Mao, C</au><au>Uckun, Fatih.M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of stereochemistry on the anti-HIV activity of chiral thiourea compounds</atitle><jtitle>Bioorganic &amp; medicinal chemistry</jtitle><addtitle>Bioorg Med Chem</addtitle><date>2004-08-01</date><risdate>2004</risdate><volume>12</volume><issue>15</issue><spage>4275</spage><epage>4284</epage><pages>4275-4284</pages><issn>0968-0896</issn><eissn>1464-3391</eissn><abstract>Chiral derivatives of several substituted halopyridyl and thiazolyl PETT compounds were synthesized as non-nucleoside inhibitors of the reverse transcriptase (RT) enzyme (NNRTI) of the human immunodeficiency virus (HIV-1). Molecular modeling studies indicated that because of the asymmetric geometry of the NNRTI binding pocket, the R stereoisomers would fit the NNRTI binding pocket of the HIV-1 RT much better than the corresponding S stereoisomers, as reflected by their 10 4-fold lower K i values. Chiral derivatives of several substituted halopyridyl and thiazolyl PETT compounds were synthesized as non-nucleoside inhibitors of the reverse transcriptase (RT) enzyme (NNRTI) of the human immunodeficiency virus (HIV-1). Molecular modeling studies indicated that because of the asymmetric geometry of the NNRTI binding pocket, the R stereoisomers would fit the NNRTI binding pocket of the HIV-1 RT much better than the corresponding S stereoisomers, as reflected by their 10 4-fold lower K i values. The R stereoisomers of several PETT derivatives inhibited recombinant RT in vitro with lower IC 50 values than their enantiomers. The active compounds were further evaluated for their ability to inhibit HIV-1 replication in human peripheral blood mononuclear cells (PBMC). All the R isomers once again showed potent anti-HIV activity and inhibited the replication of the HIV-1 strain HTLVIIIB in peripheral blood mononuclear cells (PBMC) at nanomolar concentrations whereas their enantiomers were substantially less potent. The lead compounds in the respective groups were further tested against the NNRTI-resistant HIV strains, A17 (Y181C mutant), and A17Var (Y181C+K103N mutant) and RT MDR (V106N). The results showed that the lead compounds were several logs more potent than the standard NNRTI nevirapine. Structure–activity relationship studies also revealed a preference for the pyridyl unit with halo substitutions primarily at 5-position demonstrating the importance of regiochemistry. Our data provides experimental evidence that the stereochemistry as well as regiochemistry of NNRTI can profoundly affect their anti-HIV activity.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>15246104</pmid><doi>10.1016/j.bmc.2004.04.050</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0968-0896
ispartof Bioorganic & medicinal chemistry, 2004-08, Vol.12 (15), p.4275-4284
issn 0968-0896
1464-3391
language eng
recordid cdi_proquest_miscellaneous_66695811
source MEDLINE; Elsevier ScienceDirect Journals
subjects Anti-HIV Agents - chemical synthesis
Anti-HIV Agents - chemistry
Anti-HIV Agents - pharmacology
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antiviral agents
Biological and medical sciences
Drug Evaluation, Preclinical
HIV-1 - drug effects
Humans
Medical sciences
Models, Molecular
Molecular Conformation
Pharmacology. Drug treatments
Reverse Transcriptase Inhibitors - chemical synthesis
Reverse Transcriptase Inhibitors - chemistry
Reverse Transcriptase Inhibitors - pharmacology
Stereoisomerism
Structure-Activity Relationship
Thiourea - chemical synthesis
Thiourea - chemistry
Thiourea - pharmacology
Virus Replication - drug effects
title Effect of stereochemistry on the anti-HIV activity of chiral thiourea compounds
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T01%3A16%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20stereochemistry%20on%20the%20anti-HIV%20activity%20of%20chiral%20thiourea%20compounds&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry&rft.au=Venkatachalam,%20T.K&rft.date=2004-08-01&rft.volume=12&rft.issue=15&rft.spage=4275&rft.epage=4284&rft.pages=4275-4284&rft.issn=0968-0896&rft.eissn=1464-3391&rft_id=info:doi/10.1016/j.bmc.2004.04.050&rft_dat=%3Cproquest_cross%3E66695811%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66695811&rft_id=info:pmid/15246104&rft_els_id=S096808960400389X&rfr_iscdi=true